More than 70% of people diagnosed with cancer in the United States now survive for five years or more, a milestone experts ...
First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET amplification after progression on prior EGFR-TKI treatment - ...
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...
Equity-Insider.com News Commentary ? The precision oncology market is hitting a massive growth spurt, projected to rocket ...
While the findings are positive overall, survival increases since the mid-1990s are especially notable for more fatal cancers ...
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
The five-year survival rate for all cancers in the U.S. has reached 70% for the first time, according to a report published ...
In BREAKWATER, EC plus FOLFIRI achieved a 64.4% response rate and showed a trend toward improved overall survival in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback